ValiRx - Positive results from VAL101
VAL
Thu, 19 Apr 2018, 12:15pm BST
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Industry: Health Care
Contact: +44 (0)2476 796496
Barling Way
https://www.valirx.com/
ValiRx Plc, the clinical stage biotechnology company, is pleased to announce positive VAL101 results, that are shown to be effective in inducing apoptosis (programmed cell death) in cancer cell models. The results show superior apoptotic effect in comparison to currently available reagents.
